• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Life Sciences
  • Investments
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage

Plexāā Launches Wearable Device and App to Prepare Patients for Breast Surgery

by Jasmine Pennic 10/02/2025 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

What You Should Know: 

– Plexāā, a medtech company focused on improving surgical outcomes, has announced the U.S. launch of its BLOOM43 platform on the first day of Breast Cancer Awareness Month. 

– The platform combines a wearable preconditioning medical device with a companion app, both developed to prepare patients for breast surgery. The launch addresses a significant need, as surveys show that a majority of patients feel both physically (61%) and mentally (71%) underprepared for breast surgery.


Boosting Tissue Health Before the First Incision

Breast surgery—whether oncological, reconstructive, or cosmetic—carries risks, with wound complications occurring in up to 30% of reconstruction or implant procedures. Skin necrosis (tissue death) due to compromised blood flow remains a critical concern, often requiring additional procedures, delaying healing, and increasing costs.

The BLOOM43 device is the first-ever wearable to deliver Supraphysiological Preconditioning™. This novel, evidence-based technique works by precisely heating the skin at the intended surgical site, which stimulates the release of heat shock proteins and enhances blood flow.

In clinical trials, Supraphysiological Preconditioning has been shown to:

  • Decrease the absolute risk of skin necrosis by 24%.
  • Reduce the number of required follow-up surgeries by 50%.
  • Reduce hospital stays by two days and outpatient follow-ups by 70%.

Empowering Patients with a Holistic Prehab Program

The BLOOM43 device is a non-invasive, drug-free, hands-free wearable that patients use at home, typically the night prior to surgery.

Complementing the device is a thorough and evidenced-based Prehab™ program delivered through the companion app. The app offers guidance on pre-op nutrition and physical health, along with expert content, personalized Prehab and rehab programs, and a supportive community.

According to Dr. Saahil Mehta, CEO and founder of Plexāā, BLOOM43 gives women a way to make critical improvements to tissue health before the first incision, empowering and supporting patients at every step of the journey. A patient and nine-year breast cancer survivor, Nichole W. Owens, shared that using the device before her most recent surgery made her feel “empowered and prepared”.

Availability

The BLOOM43 device is now being prescribed by surgeons and is available for hospitals, surgical centers, and clinics across the U.S.. The companion app is available globally, and U.S. patients can directly order the HSA- and FSA eligible medical device with a prescription.

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Breast Cancer

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Interview

The AI Paradox in Healthcare: Notable CEO Shares Why Moving Too Slowly is a Greater Risk

Most-Read

Pfizer and Trump Administration Announce Landmark Agreement to Lower Drug Costs

Pfizer and Trump Administration Announce Landmark Agreement to Lower Drug Costs

KLAS Report: Epic's Native Ambient Speech Tool Reshapes Customer AI Strategies

KLAS Report: Epic’s Native Ambient Speech Tool Reshapes Customer AI Strategies

Epic Unveils MyChart Central and New APIs to Advance Interoperability at Open@Epic

Epic Outlines Roadmap for Next-Generation Data Sharing at Open@Epic

Epic Launches Comet: A New AI Platform to Predict Patient Health Journeys

Epic Launches Comet: A New AI Platform to Predict Patient Health Journeys

RevSpring to Acquire Kyruus Health, Creating a Unified Patient Experience

RevSpring to Acquire Kyruus Health, Creating a Unified Patient Experience

Oracle Confirms Layoffs in Kansas City

Oracle Confirms Layoffs in Kansas City

Philips Future Health Index 2025: AI and Digital Tech Can Help Solve Cardiac Care Crisis

Philips Future Health Index 2025: AI and Digital Tech Can Help Solve Cardiac Care Crisis

Optain Health Secures $26M to Advance AI-Powered Retinal Screening

Optain Health Secures $26M for AI-Powered Retinal Screening

Sutter Health and Epic Launch "Sutter Sync" to Optimize Remote Chronic Care

Sutter Health and Epic Launch “Sutter Sync” to Optimize Remote Chronic Care

Patient Square Capital Acquires Premier in $2.6B Deal

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |